BPC-157 · For rotator cuff injury

BPC-157 for rotator cuff injuries

You tweaked your shoulder. Strain, partial tear, or impingement. BPC-157 worth trying?

S-Tier Recovery Moderate anecdotal

New to peptides? Start with the foundations ->

Why people use BPC-157 for rotator cuff injury

You tweaked your shoulder. Strain, partial tear, or impingement. BPC-157 worth trying? The short answer: yes, this is one of the more-discussed uses for BPC-157 - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering BPC-157 for rotator cuff injury.

What the evidence says

Evidence tier: Moderate anecdotal. Strong real-world anecdotal track record; mechanism extrapolates from related research.

Most popular off-label use among recreational athletes 35+.
Anecdotal reports particularly strong for partial tears that haven't responded to PT.
No RCTs specific to rotator cuff exist; mechanism extrapolates from tendon healing data.

Protocol notes

Subcutaneous injection in shoulder area or systemic dosing. 250-500mcg/day for 4-6 weeks.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

Most people run 250 to 500 micrograms (a tiny amount, less than a drop) per day for about four to six weeks. Inject just under the skin (subQ, the easy fat-pad shot) near the injury when you can. Then stop and reassess. Always with a doctor.

Typical starting dose: 250 mcg per day for the first 3 to 5 days. Some clinicians start at 200 mcg to test tolerance.
Typical maintenance dose: 250 to 500 mcg per day, usually split into two shots (morning and evening) or one shot near the injury site.
Frequency: Daily, often split AM and PM. Some protocols use a single daily injection near the injury site.
Cycle length: 4 to 6 weeks of daily use is the standard cycle.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full BPC-157 directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine